SCHEMBL21628650

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL21628867	0.90	LMNA (0.49)	LMNAKMT2AATMKDRPDGFRB
	SCHEMBL21628667	0.90	LMNA (0.49)	LMNAKMT2AATMKDRPDGFRB
	SCHEMBL21628440	0.90	LMNA (0.48)	LMNAKMT2AMAPTPTGER4MAPK1
	SCHEMBL21628605	0.88	LMNA (0.47)	LMNAKMT2AATMKDRPDGFRB
	SCHEMBL21628570	0.87	LMNA (0.46)	LMNAKMT2AATMKDRPDGFRB
	SCHEMBL21628567	0.87	MAOB (0.57)	LMNAKMT2ASMN1; SMN2KDM4EMAPT
	SCHEMBL21628565	0.86	RAF1 (0.48)	LMNALIPESMN1; SMN2KDM4EMAPT
	SCHEMBL30773357	0.86	LMNA (0.56)	LMNAKMT2AATMKDRLIPE
	SCHEMBL27335162	0.86	LMNA (0.56)	LMNAKMT2AATMKDRLIPE
	SCHEMBL21628625	0.86	TDP1 (0.46)	LMNAKMT2AATMKDRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.